Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
4.330
+0.050 (1.17%)
At close: Dec 5, 2025, 4:00 PM EST
4.380
+0.050 (1.15%)
After-hours: Dec 5, 2025, 7:48 PM EST
Vistagen Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 5, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| Market Capitalization | 171 | 72 | 143 | 27 | 256 | 305 | |
| Market Cap Growth | 131.73% | -49.43% | 421.73% | -89.32% | -16.12% | 1309.99% | |
| Enterprise Value | 96 | -15 | 18 | 5 | 176 | 211 | |
| Last Close Price | 4.33 | 2.50 | 5.28 | 3.74 | 37.20 | 63.90 | |
| PS Ratio | 195.14 | 148.47 | 134.11 | -120.48 | 230.95 | 280.23 | |
| PB Ratio | 2.54 | 1.02 | 1.25 | 2.26 | 3.96 | 3.11 | |
| P/TBV Ratio | 2.58 | 1.02 | 1.25 | 2.26 | 3.96 | 3.32 | |
| EV/Sales Ratio | 132.74 | - | 17.28 | - | 158.30 | 193.50 | |
| Debt / Equity Ratio | 0.03 | 0.02 | 0.02 | 0.22 | 0.05 | 0.04 | |
| Asset Turnover | 0.01 | 0.01 | 0.02 | - | 0.01 | 0.02 | |
| Quick Ratio | 5.66 | 6.38 | 23.26 | 3.64 | 11.88 | 24.62 | |
| Current Ratio | 5.79 | 6.51 | 23.56 | 3.83 | 12.32 | 24.86 | |
| Return on Equity (ROE) | -78.13% | -55.68% | -46.47% | -154.30% | -58.62% | -36.78% | |
| Return on Assets (ROA) | -44.62% | -33.64% | -28.52% | -77.39% | -32.65% | -19.66% | |
| Return on Capital (ROIC) | -50.22% | -37.16% | -31.46% | -89.75% | -35.19% | -21.28% | |
| Return on Capital Employed (ROCE) | -97.30% | -78.00% | -27.90% | -358.90% | -69.40% | -17.20% | |
| Earnings Yield | -36.39% | -71.26% | -20.58% | -216.63% | -18.65% | -5.87% | |
| FCF Yield | -31.08% | -58.61% | -18.13% | -182.55% | -17.75% | -4.04% | |
| Buyback Yield / Dilution | -7.22% | -59.53% | -178.13% | -5.45% | -129.85% | -96.34% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.